Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
{{familytree | | | | | | | | | E02 | | | | | | | E02=Gender specific tests}} | {{familytree | | | | | | | | | E02 | | | | | | | E02=Gender specific tests}} | ||
{{familytree | | | | | | | |,|-|^|-|.| | | | | | }} | {{familytree | | | | | | | |,|-|^|-|.| | | | | | }} | ||
{{familytree | {{familytree | | | | | | |F01| | | |F02| | | | | |F01='''Male'''<br> • PSA <br> • aFP <br> • BHCG|F02='''Female'''<br> • Mammography <br> • Ultrasound or pelvic CT}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 18:21, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Adenocarcinoma and poorly differntiated carcinoma | Neuroendocrine carcinoma | |||||||||||||||||||||||||||||||||||||
| Gender specific tests | |||||||||||||||||||||||||||||||||||||||
| Male • PSA • aFP • BHCG | Female • Mammography • Ultrasound or pelvic CT | ||||||||||||||||||||||||||||||||||||||